Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
BMC Gastroenterology|July 12, 2022
Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-upPaul J Clark, Patricia C Valery, James Ward, et al.
Hepatology Communications|June 27, 2025
Prevalence and outcomes of steatotic liver disease subtypes in older adultsDaniel Clayton-Chubb, Ammar Majeed, Isabella Commins, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2026
Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty SurveyTatyana Kushner, Maria Buti, Mohamed El-Kassas, et al.
Hepatology Communications|May 2, 2024
Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitisNatassia Tan, Natalie Ngu, Thomas Worland, et al.
Journal of Gastroenterology and Hepatology|July 8, 2026
Chronic Viral Hepatitis With MASLD: Implications for Clinical and Patient-Reported OutcomesGeorge Papatheodoridis, Maria Buti, Yusuf Yilmaz, et al.
Antiviral Therapy|April 20, 2017
Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL studyJohn Lubel, Simone Strasser, Katherine A Stuart, et al.
World Journal of Hepatology|November 17, 2021
Clinical outcomes of patients with two small hepatocellular carcinomasAnh Duy Pham, Karl Vaz, Zaid S Ardalan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 21, 2017
Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard TherapyStuart K Roberts, Ricky Lim, Simone Strasser, et al.
Journal of Viral Hepatitis|January 5, 2023
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, et al.
Springerplus|September 3, 2016
A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3Graham R Foster, Kazuaki Chayama, Wan-Long Chuang, et al.
Pageof 20